Prexton Therapeutics

Parkinson’s drugs that target the metabotropic glutamate receptors.

placePlan Les Ouates, Geneva, Switzerland calendar_todayFounded 2012 groups5 employees language prextontherapeutics.com

Innovation

6 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 576 times.

YearFilings
20141
20161
20172
20185
20192
20202
20212

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital467%
Accelerator & incubator117%
Other / undisclosed117%
Coming soon